Matthew Vesely, MD, PhD, FAAD
SESSIONS
No sessions scheduled for this speaker.
DISCLOSURES
Aclaris Therapeutics Inc. – Investigator(Grants/Research Funding); Almirall – Consultant (1099 relationship)(Fees); First Tracks Biotherapeutics – Advisory Board(Fees); Priovant Therapeutics – Consultant (1099 relationship)(Fees); Regeneron – Employee(Salary);